Apr 2023 Articles

Articles
From the EAS: frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Kronenberg F, Mora S, Stroes ESG, et al.
Journal:
Atherosclerosis

First published: April 28, 2023 DOI: 10.1016/j.atherosclerosis.2023.04.012
View
- Share
Articles
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
Ray KK, Haq I, Bilitou A, et al.
Journal:
Lancet Reg Health Eur

First published: April 5, 2023 DOI: 10.1016/j.lanepe.2023.100624
View
- Share
Articles
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.
Journal:
Circulation

First published: April 3, 2023 DOI: 10.1161/CIRCULATIONAHA.122.062557
View
- Share
Articles
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis
Lee SH, Lee YJ, Heo JH, et al.
Journal:
J Am Coll Cardiol

First published: April 3, 2023 DOI: 10.1016/j.jacc.2023.02.007
View
- Share
Articles
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation
Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.
Journal:
Eur Heart J

First published: April 3, 2023 DOI: 10.1093/eurheartj/ehad170
View
- Share
Articles
Lipoprotein(a): cardiovascular risk and emerging therapies
Fujino M, Nicholls SJ
Journal:
Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593
View
- Share

Apr 2023 Articles

Articles

From the EAS: frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Kronenberg F, Mora S, Stroes ESG, et al.

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Articles

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.

Articles

Lipoprotein(a): cardiovascular risk and emerging therapies

Fujino M, Nicholls SJ

Articles

From the EAS: frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Kronenberg F, Mora S, Stroes ESG, et al.

Share

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Share

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Share

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Share

Articles

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.

Share

Articles

Lipoprotein(a): cardiovascular risk and emerging therapies

Fujino M, Nicholls SJ

Share